Meritxell Sabidó et al <br/><br/>
Subcutaneous Interferon-β1a Does Not Increase the Risk of Stroke in Patients with Multiple Sclerosis: Analysis of Pooled Clinical Trials and Post-Marketing Surveillance 

<br/><br/><label>Subjects--Topical Terms: </label><br/>Computer science, information & general works